BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/27/2025 4:03:43 AM | Browse: 7 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 113150
Country Morocco
Category Oncology
Manuscript Type Letter to the Editor
Article Title Shifting paradigm in locally advanced resectable gastric and gastroesophageal junction cancers
Manuscript Source Unsolicited Manuscript
All Author List Nabil Ismaili
Funding Agency and Grant Number
Corresponding Author Nabil Ismaili, Associate Professor, Chief Physician, Director, MD, Department of Medical Oncology, Mohammed VI Faculty of Medicine, Mohammed VI University of Health Sciences, Boulevard Mohammed Taieb Naciri, Commune Hay Hassani, Casablanca 20000, Morocco. ismailinabil@yahoo.fr
Key Words Gastric cancer; Locally advanced; Perioperative therapy; Chemotherapy; Immunotherapy
Core Tip The recent real-world study by Wang et al adds to the growing evidence that perioperative sintilimab combined with oxaliplatin and S-1 chemotherapy improves pathological response and overall survival in non-metastatic gastric cancer, with a manageable safety profile. However, the conclusions are tempered by the study’s retrospective design, limited power, and the use of a potentially suboptimal chemotherapy backbone. Crucially, this data aligns with the positive results of the large phase III MATTERHORN trial, solidifying the paradigm shift. The collective evidence now strongly suggests that adding immunotherapy to perioperative chemotherapy enhances cure rates for locally advanced resectable gastric and gastroesophageal junction cancers, establishing this combination as a new standard of care.
Citation Ismaili N. Shifting paradigm in locally advanced resectable gastric and gastroesophageal junction cancers. World J Gastrointest Oncol 2025; In press
Received
2025-08-18 02:31
Peer-Review Started
2025-08-18 02:31
To Make the First Decision
Return for Revision
2025-10-27 09:12
Revised
2025-10-28 07:59
Second Decision
2025-11-27 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-11-27 04:03
Articles in Press
2025-11-27 04:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com